Epidemiology in Infection Control: A Practical Encyclopedia
Epidemiology is the study of the distribution and determinants of health-related events in populations and the application of this knowledge to control health problems.
In healthcare, epidemiology in infection control helps identify who is becoming infected, where and when infections occur, which factors are associated with infection, how transmission may be occurring, and whether prevention measures are working. CDC emphasizes comparison, measurement, descriptive analysis, and analytic investigation as core elements of applied epidemiology.
Part 1 — Foundations of Epidemiology
1. What Is Epidemiology?
Epidemiology examines health-related events within populations rather than focusing only on individual patients.
Its main purposes are to:
Describe disease occurrence
Identify risk factors
Detect changes in disease patterns
Investigate outbreaks
Guide prevention and control
Evaluate interventions
In infection prevention, epidemiology provides the framework for converting clinical and laboratory data into actionable information.
2. Epidemiologic Triad
The epidemiologic triad is a basic framework for understanding infectious disease occurrence.
It consists of:
Agent: The infectious organism or other disease-causing factor
Host: The person or population that can develop infection
Environment: External conditions that affect exposure or transmission
The interaction among these factors influences whether and how infection occurs.
3. Population at Risk
The population at risk is the group of people who are capable of developing the health outcome being studied.
Correctly defining the population at risk is essential because epidemiologic measures depend on an appropriate denominator.
Examples in healthcare may include:
Patients admitted to an ICU
Patients with central lines
Surgical patients
Healthcare workers
Residents of a long-term care facility
Part 2 — Measuring Disease Occurrence
4. Count, Ratio, Proportion, and Rate
Epidemiologic measurements describe the occurrence of health events.
Count
The number of events or cases.
Ratio
A comparison of two quantities.
Proportion
A type of ratio in which the numerator is included in the denominator.
Rate
A measure that incorporates the occurrence of an event over a specified population and period.
These measures form the basis for describing disease frequency.
5. Incidence
Incidence measures the occurrence of new cases in a population during a defined period.
It is used to describe the risk or rate at which new infections develop.
Incidence is particularly useful for:
HAI surveillance
Comparing populations
Monitoring trends
Evaluating prevention programmes
CDC distinguishes incidence from prevalence because incidence includes new cases, whereas prevalence includes existing cases.
6. Prevalence
Prevalence describes the proportion of a population that has a condition at a specific time or during a specified period.
It includes both:
Existing cases
New cases present during the period
Prevalence is useful for describing the overall burden of a condition in a population.
7. Attack Rate
An attack rate is an incidence proportion commonly used during outbreaks to describe the proportion of an exposed or defined population that becomes ill during a specified period.
It is particularly useful when investigating a common exposure or a defined outbreak population.
8. Mortality Rate and Case-Fatality Proportion
Mortality rate
Measures deaths occurring in a population during a defined period.
Case-fatality proportion
Describes the proportion of identified cases of a disease who die from that disease.
These measures provide information about the severity and outcome of infectious diseases.
Part 3 — Descriptive Epidemiology
9. Descriptive Epidemiology
Descriptive epidemiology describes the occurrence of disease according to:
Person
Place
Time
It answers questions such as:
What is happening?
How much is occurring?
When is it occurring?
Where is it occurring?
Among whom is it occurring?
CDC identifies these dimensions as fundamental to organizing and interpreting epidemiologic data.
10. Person
The person dimension describes characteristics of affected individuals or groups.
Variables may include:
Age
Sex
Occupation
Clinical characteristics
Underlying conditions
Exposure history
Person-based patterns can help identify groups at increased risk.
11. Place
The place dimension describes where cases or exposures occur.
In healthcare settings, this may include:
Hospital
Ward
ICU
Operating room
Procedure room
Patient room
Specific equipment or environmental locations
Spatial patterns can help identify possible transmission pathways or common sources.
12. Time
The time dimension describes when disease or exposure occurs.
Time analysis can reveal:
Increasing or decreasing trends
Seasonal patterns
Clusters
Changes following an intervention
Possible exposure periods
Time is particularly important during outbreak investigations.
13. Epidemic Curve
An epidemic curve is a graph showing the number of incident cases over time.
It can help investigators:
Visualize the timing of cases
Identify clusters
Estimate the likely exposure period
Develop hypotheses about transmission
Distinguish possible outbreak patterns
CDC notes that epidemic curves may provide clues about transmission modes such as point-source or person-to-person spread.
Part 4 — Risk Factors and Association
14. Risk Factor
A risk factor is a characteristic, exposure, behavior, condition, or circumstance associated with an increased likelihood of a health outcome.
Examples in healthcare may include:
Invasive devices
Surgery
Immunosuppression
Prolonged hospitalization
Antimicrobial exposure
Environmental exposure
A risk factor can be associated with an outcome without necessarily being a proven cause.
15. Measures of Association
Measures of association quantify the relationship between an exposure and an outcome.
Common measures include:
Risk Ratio (RR)
Odds Ratio (OR)
Prevalence Ratio (PR)
Prevalence Odds Ratio (POR)
The appropriate measure depends on the study design and data structure.
16. Risk Ratio
The risk ratio (RR) compares the risk of disease or another outcome in an exposed group with the risk in an unexposed group.
It is commonly used in cohort studies.
CDC describes RR as the preferred measure of association for cohort data.
17. Odds Ratio
The odds ratio (OR) compares the odds of exposure between cases and controls.
It is the principal measure of association for case-control studies, where the incidence or attack rate cannot generally be calculated directly.
18. Confounding
Confounding occurs when a third factor distorts the observed relationship between an exposure and an outcome.
A confounder is associated with both the exposure and the outcome but is not a consequence of the exposure.
Confounding must be considered when interpreting epidemiologic associations.
19. Bias
Bias is a systematic error that can produce an incorrect estimate of an exposure-outcome relationship.
Important forms include:
Selection bias
Information bias
Other sources of error, including confounding and investigator error, can also distort epidemiologic findings.
Part 5 — Epidemiologic Study Designs
20. Cohort Study
A cohort study follows groups defined by exposure and compares the occurrence of an outcome between exposed and unexposed groups.
It can be:
Prospective
Retrospective
Risk ratios and incidence measures can commonly be calculated in cohort studies.
21. Case-Control Study
A case-control study begins with people who have the outcome of interest and a comparison group without the outcome.
Investigators then compare previous exposures between the groups.
Case-control studies are particularly useful when:
The outcome is uncommon
The population at risk is difficult to define
An outbreak requires rapid hypothesis testing
The odds ratio is commonly used for analysis.
22. Cross-Sectional Study
A cross-sectional study assesses exposure and outcome at a particular point in time or during a defined period.
It is commonly used to estimate prevalence and describe the distribution of health conditions in a population.
23. Descriptive and Analytic Epidemiology
Descriptive epidemiology
Describes the distribution of disease.
Analytic epidemiology
Tests hypotheses about associations between exposures and outcomes.
In outbreak investigations, descriptive epidemiology generally helps generate hypotheses, while analytic epidemiology can then be used to evaluate those hypotheses.
Part 6 — Epidemiologic Surveillance
24. Epidemiologic Surveillance
Epidemiologic surveillance is the ongoing, systematic collection, analysis, interpretation, and use of health-related data for public health action.
Surveillance can be used to:
Detect changes in disease occurrence
Identify outbreaks
Monitor trends
Identify high-risk populations
Evaluate interventions
Support resource allocation
WHO identifies HAI surveillance as a core component of IPC programmes.
25. HAI Surveillance
Healthcare-associated infection surveillance monitors infections acquired in healthcare settings using defined populations, case definitions, and standardized data collection.
It can include surveillance of:
Surgical site infections
CLABSI
CAUTI
VAP
Other healthcare-associated infections
Antimicrobial resistance
Surveillance data should be interpreted and used to support prevention and quality improvement. WHO's 2024 HAI surveillance handbook specifically addresses objectives, methods, case definitions, and implementation at national and facility levels.
26. Case Definition
A case definition specifies the criteria used to determine whether an individual should be classified as a case.
It may include:
Clinical findings
Laboratory results
Demographic characteristics
Location
Time period
Exposure information
CDC notes that case definitions should be sufficiently broad during early investigation and may be refined as information develops.
27. Active and Passive Surveillance
Active Surveillance
Healthcare or public health personnel actively search for cases and collect relevant information.
Passive Surveillance
Cases are reported through routine reporting systems without the same level of active case finding.
Active surveillance generally requires more resources but can provide more complete case detection.
28. Surveillance Data Quality
Useful surveillance depends on reliable data.
Important characteristics include:
Accurate case definitions
Complete reporting
Consistent data collection
Appropriate denominators
Timely analysis
Appropriate interpretation
Feedback to relevant teams
Poor-quality data can lead to misleading estimates and inappropriate conclusions.
Part 7 — Outbreak Epidemiology
29. Outbreak
An outbreak is the occurrence of more cases of a disease than expected in a particular area, population, or period.
An outbreak generally requires a timely epidemiologic response.
30. Cluster
A cluster is an aggregation of cases or events occurring close together in time or place.
A cluster may represent an outbreak, but additional investigation is often required to determine whether the number of cases exceeds what would normally be expected.
31. Outbreak Investigation
A typical outbreak investigation includes:
Verify the outbreak.
Establish a case definition.
Identify and count cases.
Describe cases by person, place, and time.
Develop hypotheses.
Evaluate hypotheses analytically.
Implement control measures.
Communicate findings.
Reassess the outbreak and control measures.
CDC's field investigation framework emphasizes rapid but methodologically appropriate investigation and simultaneous use of epidemiologic, laboratory, and other expertise when needed.
32. Contact Tracing
Contact tracing identifies people who have had relevant exposure to an infected person or infectious source.
It can support:
Case finding
Risk assessment
Testing
Monitoring
Prevention of further transmission
The approach depends on the pathogen, transmission route, and public health context.
33. Source and Transmission Investigation
Outbreak investigations should consider:
Common sources
Person-to-person transmission
Environmental reservoirs
Contaminated equipment
Healthcare procedures
Staff or patient exposures
Epidemiologic findings should be integrated with microbiological, environmental, and clinical information.
Part 8 — Epidemiology in Healthcare Infection Control
34. Healthcare Epidemiology
Healthcare epidemiology applies epidemiologic methods to problems affecting patients, healthcare workers, and healthcare delivery.
Its applications include:
HAI surveillance
Outbreak investigation
IPC programme evaluation
Antimicrobial resistance surveillance
Device-associated infection monitoring
Environmental investigations
Quality improvement
35. Device-Associated Infection Surveillance
Healthcare epidemiology can monitor infections associated with devices such as:
Central lines
Urinary catheters
Mechanical ventilators
Surveillance should use standardized definitions and appropriate denominators so that rates can be interpreted correctly.
36. Healthcare-Associated Infection Rates
HAI rates should be calculated using an appropriate population or exposure denominator.
Depending on the surveillance system, denominators may include:
Patient-days
Device-days
Surgical procedures
Number of admissions
Using the wrong denominator can substantially distort interpretation.
37. Device Utilization
Device utilization describes the extent to which a population is exposed to a healthcare device.
It can be useful for:
Assessing exposure
Comparing device use
Supporting HAI interpretation
Identifying opportunities for prevention
Device utilization should be interpreted alongside infection rates rather than independently.
Part 9 — Epidemiologic Interpretation
38. Statistical Significance
Statistical tests help assess whether an observed difference or association could reasonably be explained by chance under a specified statistical model.
A statistically significant result does not, by itself, establish causation.
CDC emphasizes that epidemiologic interpretation must also consider study design, bias, confounding, data quality, and other possible explanations.
39. Confidence Interval
A confidence interval (CI) describes the uncertainty around an estimated measure.
For measures such as RR and OR, the CI provides information about:
Precision
The range of compatible estimates
Statistical uncertainty
Wider intervals generally indicate less precise estimates than narrower intervals.
40. Causation
An observed epidemiologic association does not automatically demonstrate causation.
Before interpreting an association as causal, investigators should consider:
Temporal sequence
Strength of association
Consistency
Biological plausibility
Dose-response relationship
Alternative explanations
Bias
Confounding
CDC specifically emphasizes evaluating chance, selection bias, information bias, confounding, and investigator error before interpreting an association as causal.
41. Data Visualization
Epidemiologic data can be communicated using:
Tables
Bar charts
Line graphs
Epidemic curves
Maps
Stratified analyses
Good visualization should make patterns in person, place, and time easier to recognize rather than simply displaying large amounts of data.
Part 10 — Epidemiology for Infection Prevention
42. Using Epidemiology to Guide IPC
Epidemiology helps IPC teams move from identifying infections to understanding where, when, among whom, and under what circumstances they occur.
This information can guide:
Prevention priorities
Resource allocation
Targeted interventions
Staff education
Surveillance design
Outbreak response
43. Evaluating IPC Interventions
Epidemiologic methods can be used to assess whether an intervention is associated with changes in infection occurrence.
Evaluation may compare:
Before and after implementation
Exposed and unexposed groups
Different units
Different time periods
Interpretation should account for changes in case definitions, diagnostic practices, patient populations, and other factors that may influence observed rates.
44. Epidemiology and Antimicrobial Resistance
Epidemiology is essential for understanding the distribution and spread of antimicrobial-resistant organisms.
Surveillance can monitor:
Resistant organisms
Resistance patterns
High-risk populations
Healthcare-associated transmission
Temporal trends
Microbiology and epidemiology should therefore work together when investigating AMR.
Microbiology in infection control provides the link between microorganisms and the practical prevention of infection in healthcare.
Understanding the organism, its ecology, colonization patterns, transmission route, antimicrobial susceptibility, environmental persistence, and response to disinfection or sterilization helps healthcare teams make informed IPC decisions.
The essential relationship can be summarized as:
Microorganism → Colonization/Infection → Transmission → Detection → Characterization → Intervention → Surveillance
Microbiology is therefore not limited to identifying pathogens in the laboratory. It is an integral part of infection prevention, outbreak response, antimicrobial stewardship, medical-device safety, and antimicrobial-resistance surveillance.